Form 4 for AMLX Amylyx Pharmaceuticals, Inc.
Accepted 2025-01-28 00:00:00 ET · period of report 2025-01-24 · accession 0000950170-25-009913 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-28 | 2025-01-24 | AMLX | MILNE GEORGE M JR | Dir | G - Gift | $0.00 | -27.9K | 830.7K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-24 | G | D | 27,910 | $0.00 | 830,661 | D | — | — | (F2) These shares of common stock remain subject to a lock-up agreement pursuant to which they cannot be sold prior to March 11, 2025 without the consent of Leerink Partners LLC, subject to certain exceptions. |